Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
15%
OVERLAP
BY WEIGHT
14
# OF OVERLAPPING
HOLDINGS
PSCH
73
HOLDINGS
21%
ALSO IN XPH
XPH
57
HOLDINGS
24%
ALSO IN PSCH
SECTOR DRIFT (PSCH minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PSCH |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
LIGAND PHARMACEUTICALS-CL B | 3.3% | 2.2% | 2.2% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | 2.0% | 2.5% | 2.0% |
|
ORGANON & CO. | 1.9% | 2.0% | 1.9% |
|
LIQUIDIA TECHNOLOGIES, INC. | 1.7% | 1.3% | 1.3% |
|
SUPERNUS PHARMACEUTICALS INC | 1.2% | 2.0% | 1.2% |
PSCH Overweight Relative to XPH
|
GLAUKOS CORP | 7.1% |
|
PROTAGONIST THERAPEUTICS, INC. | 4.8% |
|
TG THERAPEUTICS INC | 4.4% |
 |
ALKERMES PLC | 3.9% |
|
TELEFLEX INC | 3.0% |
|
RADNET INC | 2.6% |
|
MERIT MEDICAL SYSTEMS INC | 2.6% |
|
PTC THERAPEUTICS INC | 2.5% |
|
CONCENTRA GROUP HOLDINGS PAR | 2.4% |
|
INTEGER HOLDINGS CORPORATION | 2.2% |
PSCH Underweight Relative to XPH
|
VERADERMICS INC | -2.8% |
|
ELI LILLY & CO | -2.5% |
|
VIATRIS, INC. | -2.3% |
|
MAZE THERAPEUTICS INC | -2.3% |
|
ROYALTY PHARMA PLC CLASS A | -2.2% |
|
PFIZER INC | -2.2% |
|
ZOETIS INC | -2.2% |
|
SEPTERNA INC | -2.2% |
|
JOHNSON & JOHNSON | -2.0% |
|
MERCK & CO. INC. | -2.0% |